AzTrials
AzTrials

Eye-trackingEyeTrackingFPNCT04886245

Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.

A study testing Video sequences in people with Eye-tracking and Facial Palsy, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The facial palsy concerns between 15 and 40 people per 100000 inhabitants. They are of various etiologies such as infectious, tumoral, traumatic or idiopathic. It has variable severities with sometimes heavy functional repercussions and different recovery potentials. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Eye-tracking, Facial Palsy
What is being tested?
Video sequences
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteFrance
Study dates
31 Jan 2020to Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • for patient with facial paralysis:
  • Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated
  • Patient providing written informed consent
  • Patient aged ≥ 18 years
  • Patient affiliated to a social security system
  • for Healthy voluntary subject :
Show all 10Show fewer
  • Subject without major facial sequelae
  • Subject who provided written informed consent
  • Major subject ≥ 18 years old
  • Subject affiliated to a social security system

Who cannot join

  • for Patient with facial paralysis:
  • Patient with recent peripheral facial palsy whose total recovery is possible
  • Patient unable to provide written informed consent
  • Patient with difficulties to follow instructions and especially to stand in front of a computer screen
  • Minor patient <18 years
  • Patient under guardianship or curators or judicial safeguard
Show all 12Show fewer
  • for Healthy voluntary subject :
  • Subject with major facial sequelae
  • Subject not able to provide written informed consent
  • Subject presenting difficulties in following instructions and in particular in standing still in front of a computer screen
  • Minor subject < 18 years old
  • Subject under guardianship or curators or judicial safeguard

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU Amiens

    Amiens, 80480

    Stéphanie DAKPE, Pr, 03.22.08.90.50, dakpe.stephanie@chu-amiens.fr

    Sylvie Testellin, Pr, 03 22 08 90 50, testelin.sylvie@chu-amiens.fr

    Recruiting

Other trials in France

About this study

The facial palsy concerns between 15 and 40 people per 100000 inhabitants. They are of various etiologies such as infectious, tumoral, traumatic or idiopathic.

It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed palliative treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. In this context, patients' expectations and feelings about their care may become difficult for clinicians to apprehend.

The eye-tracking is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular. Published studies focus on the gaze of photographs, excluding any notion of dynamics and by the analysis of the gaze of outside observers, ignoring the patient's gaze.The main objective is to evaluate the attention paid to the facial side with abnormal facial movement by patients with facial paralysis compared to healthy volunteers.

Being tested
Video sequences
Keywords
facial mimics, eye-tracking, Facial Palsy
Medical subject headings
Facial Paralysis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video sequencesOther

    videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound [o], the labial protrusion on the sound [pu] and the wide smile uncovering the teeth.

    Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.

Study groups in NCT04886245
Study groupRoleWhat they receive
facial palsyExperimentalPatient with peripheral facial palsy, irrespective of grade, whether or not previously treated
Receives: Other: Video sequences
healthy volunteersSham comparator- Subject without major facial sequelae
Receives: Other: Video sequences

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation of facial fixation day number between facial palsy patients and healthy volunteers

    Measured: 30 days

  2. Incidence of facial movement abnormality between facial palsy patients and healthy volunteers

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2021
  2. Study start31 Jan 2020
  3. Primary completionJul 2027 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04886245
Sponsor's protocol ID
PI2019_843_0089
Acronym
EyeTrackingFP
Status last verified
Oct 2026
First submitted
7 May 2021
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Video sequences in people with Eye-tracking and Facial Palsy, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stéphanie DAKPE, PR (03.22.08.90.50, dakpe.stephanie@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation of facial fixation day number between facial palsy patients and healthy volunteers (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in